Skip to main content
. 2020 Jan 6;17(1):369. doi: 10.3390/ijerph17010369

Table 1.

Factors associated with older adults’ willingness for downward referral (DR).

Observations Willingness of DR Total χ2/F p-Value
Self-Initiated Doctor’s Advice Unwilling n (%)
344 (28.7) 406 (33.9) 448 (37.4) 1198
Panel 1 Socio-Demographics
Age mean ± SD 70.67 ± 6.37 70.52 ± 6.56 70.19 ± 6.42 70.44 ± 6.45 0.599 a 0.550
Gender
 Male 150 (31.0) 159 (32.9) 175 (36.2) 484 (40.4) 2.058 b 0.357
 Female 194 (27.2) 247 (34.6) 273 (38.2) 714 (59.6)
Residence
 Rural 289 (31.5) 304 (33.2) 324 (35.3) 917 (76.5) 16.546 b <0.001
 Urban 55 (19.6) 102 (36.3) 124 (44.1) 281 (23.5)
Income *
 Q1 101 (32.9) 91 (29.6) 115 (37.5) 307 (25.6) 13.757 b 0.032
 Q2 90 (30.1) 104 (34.8) 105 (35.1) 299 (25.0)
 Q3 89 (30.4) 104 (35.5) 100 (34.1) 293 (24.5)
 Q4 64 (21.4) 107 (35.8) 128 (42.8) 299 (25.0)
Marital status
 Others # 56 (25.3) 91 (41.2) 74 (33.5) 221 (18.4) 6.429 b 0.040
 Married 288 (29.5) 315 (32.2) 374 (38.3) 977 (81.6)
Education
 No education 117 (29.2) 149 (37.2) 135 (33.7) 401 (33.5) 6.002 b 0.199
 Primary 136 (29.2) 156 (33.5) 174 (37.3) 466 (38.9)
 Junior or above 91 (27.5) 101 (30.5) 139 (42.0) 331 (27.6)
Medical insurance
 UEBMI 57 (24.1) 70 (29.5) 110 (46.4) 237 (19.8) 10.504 b 0.033
 URRBMI 283 (29.9) 330 (34.9) 332 (35.1) 945 (78.9)
 Others and none 4 (25.0) 6 (37.5) 6 (37.5) 16 (1.3)
Number of NCD
 None 51 (33.8) 52 (34.4) 48 (31.8) 151 (12.6) 4.043 b 0.671
 One 106 (28.1) 125 (33.2) 146 (38.7) 377 (31.5)
 Two 114 (28.7) 130 (32.7) 153 (38.5) 397 (33.1)
 Three or above 73 (26.7) 99 (36.3) 101 (37.0) 273 (22.8)
Self-rated health
 Good 143 (33.9) 134 (31.8) 145 (34.4) 422 (35.2) 9.702 b 0.046
 Fair 99 (25.6) 142 (36.8) 145 (37.6) 386 (32.2)
 Poor 102 (26.2) 130 (33.3) 158 (40.5) 390 (32.6)
Living arrangement
 1 33 (20.5) 76 (47.2) 52 (32.3) 161 (13.4) 17.784 b 0.001
 2 244 (29.9) 269 (32.9) 304 (37.2) 817 (68.2)
 3~ 67 (30.5) 61 (27.7) 92 (41.8) 220 (18.4)
Panel 2 Related Factors Regarding PMI
Drug needed for your illness in PMI
 No 92 (26.9) 125 (36.5) 125 (36.5) 342 (28.5) 1.639 b 0.441
 Yes 252 (29.4) 281 (32.8) 323 (37.7) 856 (71.5)
Treatment effect of PMI
 Better 296 (31.2) 314 (33.1) 339 (35.7) 949 (79.2) 14.038 b 0.001
 Worse 48 (19.3) 92 (36.9) 109 (43.8) 249 (20.8)
Panel 3 Choice of Medical Institution
Preference for outpatient services when ill
 Primary 311 (29.5) 370 (35.1) 373 (35.4) 1054 (88) 15.234 b 0.019
 County-level 9 (23.1) 10 (25.6) 20 (51.3) 39 (3.3)
 Multiple level and above 20 (23.3) 21 (24.4) 45 (52.3) 86 (7.2)
 Others 4 (21.1) 5 (26.3) 10 (52.6) 19 (1.6)
Choice of inpatient service for most recent illness
 Primary 120 (34.9) 116 (33.7) 108 (31.4) 344 (28.7) 15.479 b 0.017
 County-level 102 (29.1) 120 (34.3) 128 (36.6) 350 (29.2)
 Multiple level and above 114 (24.1) 162 (34.2) 197 (41.6) 473 (39.5)
 Others 8 (25.8) 8 (25.8) 15 (48.4) 31 (2.6)
Panel 4 Perception of EMs
General understanding of EMs
 Yes 36 (28.1) 51 (39.8) 41 (32.0) 128 (10.7) 2.619 b 0.270
 No 308 (28.8) 355 (33.2) 407 (38) 1070 (89.3)
Perceived price on EMs
 High 107 (30.0) 106 (29.7) 144 (40.3) 357 (29.8) 0.384 b 0.535
 Moderate 132 (28.3) 160 (34.3) 174 (37.3) 466 (38.9)
 Low 105 (28) 140 (37.3) 130 (34.7) 375 (31.3)
Perceived quality of EMs
 Good 274 (30.3) 314 (34.8) 315 (34.9) 903 (75.4) 9.667 b 0.002
 Moderate 68 (24.5) 84 (30.2) 126 (45.3) 278 (23.2)
 Poor 2 (11.8) 8 (47.1) 7 (41.2) 17 (1.4)
Satisfaction with EMs reimbursement policy
 Satisfaction 279 (30.4) 302 (32.9) 336 (36.6) 917 (76.5) 6.474 b 0.011
 Moderate 42 (23.7) 77 (43.5) 58 (32.8) 177 (14.8)
 Dissatisfaction 23 (22.1) 27 (26) 54 (51.9) 104 (8.7)
Cost-saving effect of EMs after zero-markup policy
 Yes 327 (29.7) 382 (34.7) 393 (35.7) 1102 (92.0) 17.884 b <0.001
 No 17 (17.7) 24 (25.0) 55 (57.3) 96 (8.0)

* Income: personal yearly income; # Others: not married/divorced/widowed or others; SD: standard deviation; a one-way AVOVA; b chi-square test; UEBMI: urban employee basic medical insurance; URRBMI: urban and rural residents basic medical insurance; PMI: primary medical institutions; EMs: essential medicines.